Newsroom

Newsroom

NeoGenomics Announces Proposed Public Offering of Common Stock

Press Release
Read More

Comparison of diagnostic methodologies to detect chromosomal abnormalities.

Literature
Read More

NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter

Press Release
Read More

Expert approaches to resolving challenging areas in diagnostic pathology

Blog
Read More

NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019

Press Release
Read More

NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference

Press Release
Read More

American Registry of Pathology Expert Opinions

Literature
Read More

Characterization of TIGIT Expression Using MultiOmyx™ Hyperplexed Immunofluorescence Assay in NSCLC and melanoma

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients